* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Fisher & Paykel Healthcare's PEG Ratio or its related term are showing as below:
NZSE:FPH'
s PEG Ratio Range Over the Past 10 Years
Min: 1.18 Med: 3.15 Max: 7.33
Current: 5.26
During the past 13 years, Fisher & Paykel Healthcare's highest PEG Ratio was 7.33. The lowest was 1.18. And the median was 3.15.
NZSE:FPH's PEG Ratio is ranked worse than 81.78% of 247
companies
in the Medical Devices & Instruments industry
Industry Median: 1.79
vs NZSE:FPH: 5.26
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Fisher & Paykel Healthcare PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Fisher & Paykel Healthcare's PEG Ratio
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare's PEG Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's PEG Ratio falls into.
Fisher & Paykel Healthcare PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Fisher & Paykel Healthcare (NZSE:FPH) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Fisher & Paykel Healthcare PEG Ratio Related Terms
Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Fisher & Paykel Healthcare (NZSE:FPH) Business Description
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NZSE:FPH has been successfully added to your 